Skip to content
BIO CEO 2025: AI is a tool – not magic
The idea of AI supercharging drug development is stirring a lot of excitement. However, a realistic understanding of what AI can and can’t do […]
BIO CEO 2025: AI is a tool – not magic Read More »
Latest News
BIO CEO 2025: Exciting new directions for obesity drug research
While a couple of frontrunners have taken the early lead in the race to capture the market for obesity drugs, major pharmaceutical firms still
BIO CEO 2025: Exciting new directions for obesity drug research Read More »
John Crowley highlights Colorado’s biotech ecosystem during packed Denver tour
Colorado’s contributions to biotechnology innovation—and biotech’s importance to our health, food supply, and national security—were key themes as BIO President & CEO John F.
John Crowley highlights Colorado’s biotech ecosystem during packed Denver tour Read More »
What the Hims & Hers Super Bowl commercial gets wrong about innovation… and America
“This is America,” goes the musical refrain of the new Hims & Hers Super Bowl ad for its compounded obesity drugs. But Hims &
What the Hims & Hers Super Bowl commercial gets wrong about innovation… and America Read More »
BIO’s message to incoming CMS leadership on improving Part D access for patients
With the new administration bringing new leadership to the Centers for Medicare & Medicaid Services (CMS), one of the most significant healthcare decisions facing
BIO’s message to incoming CMS leadership on improving Part D access for patients Read More »
FDA approves Vertex’s pain treatment: A victory in the war against the opioid epidemic
Pictured: JOURNAVX bottle and tablet (Photo: Business Wire) The Jan. 30 approval of Vertex Pharmaceuticals’ JOURNAVX™ (suzetrigine), for acute pain, represents a watershed in
FDA approves Vertex’s pain treatment: A victory in the war against the opioid epidemic Read More »
What BIO’s watching in the new Congress
Reforms to prevent middlemen from driving up drug prices and legislation encouraging the development of oral medications and rare disease treatments were called top
What BIO’s watching in the new Congress Read More »
Farm to Fly Act reintroduced in Senate would give SAF wings
Legislation introduced last year to ease widespread commercialization of sustainable aviation fuel (SAF) was reintroduced Jan. 16 as one of the early measures proposed
Farm to Fly Act reintroduced in Senate would give SAF wings Read More »
Nobel and World Food Prize holders: Enable biotech innovation for food
The world needs regulatory reform and greater R&D investment to enable “moonshot” biotech innovations in food production that can meet our growing food needs,
Nobel and World Food Prize holders: Enable biotech innovation for food Read More »
Multi-billion-dollar deals at JPM Week augur a busy BIO CEO 2025
The year in biotech M&A activity got off to a promising start at JPM Week with announcements of some multi-billion-dollar deals. The flurry of
Multi-billion-dollar deals at JPM Week augur a busy BIO CEO 2025 Read More »